Study of the Thoraflex™ Hybrid Device for the Treatment of Aneurysm/dissection of the Descending Thoracic Aorta
National Observational Study of the Thoraflex™ Hybrid Vascular Prosthesis in the Replacement of the Aortic Arch and the Treatment of Aneurysm/dissection of the Descending Thoracic Aorta
1 other identifier
observational
351
1 country
37
Brief Summary
The purpose of this national observational study is to evaluate the Thoraflex™ Hybrid vascular prosthesis in the replacement of the aortic arch and the treatment of aneurysm/dissection of the descending thoracic aorta in relation to morbidity-mortality, visceral malperfusions, neurological and renal complications, endoleak and evolution of the aortic thoracic stent over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Longer than P75 for all trials
37 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2015
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedFirst Posted
Study publicly available on registry
November 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedFebruary 19, 2025
November 1, 2024
3.1 years
December 16, 2015
February 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patients who did not die, nor suffered paraplegia due to the prosthesis, nor had complications linked to the procedure and surgical conversion
Percentage of patients who did not die, nor suffered paraplegia due to the prosthesis, nor had complications linked to the procedure and surgical conversion for 30 days post-operative
30 days post-operative
Secondary Outcomes (6)
Technical success
Within 30 days of intervention; Between 3 and 6 months; then documented by the patient's clinical course up to 3 years.
Death
Within 30 days of intervention; Between 3 and 6 months; then documented by the patient's clinical course up to 3 years.
Transitory paraplegia/Para-paresis
Within 30 days of intervention; Between 3 and 6 months; then documented by the patient's clinical course up to 3 years.
Follow-up surgery
Within 30 days of intervention; Between 3 and 6 months; then documented by the patient's clinical course up to 3 years.
Complications linked to the device
Within 30 days of intervention; Between 3 and 6 months; then documented by the patient's clinical course up to 3 years.
- +1 more secondary outcomes
Study Arms (1)
Aneurysm/Dissection
Thoraflex™ Hybrid
Interventions
The Thoraflex™ Hybrid device is particularly suited to the treatment of extended lesions of the ascending aorta, the aortic arch and the descending aorta, which constitute a major challenge in cardiovascular surgery. It enables, during a single surgical operation, combination of the "Frozen Elephant Trunk" technique and a 4-branch prosthesis of the aortic arch, thus enhancing the arsenal of the surgeon in the treatment of complex diseases of the aortic arch.
Eligibility Criteria
Any patient presenting an aneurysm/dissection of the thoracic aorta of the aortic arch and/or the descending thoracic aorta and necessitating surgery of the Elephant Trunk type. To meet the requirements of the French National Authority for Health, this study will include all the patients treated with the Thoraflex™ Hybrid hybrid vascular prosthesis. Any surgeon practising in France and wishing to inplant a Thoraflex™ Hybrid hybrid vascular prosthesis will be available from the coordinating observer.
You may qualify if:
- Patient presenting an aneurysm/dissection of the thoracic aorta of the aortic arch and/or the descending thoracic aorta, and necessitating a procedure of the "Elephant Trunk" type, with the Thoraflex™ Hybrid hybrid vascular prosthesis.
You may not qualify if:
- Patient having refused to sign the Consent form to the use of his/her data.
- Patient residing abroad, for whom follow-up is not possible.
- Patient with active endocarditis
- Patient who has received a post-infarction septal repair.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vascutek Ltd.lead
Study Sites (37)
Centre Hospitalier University (University Hospital centre)
Amiens, France
CHU Angers
Angers, France
CH De La Region D Annecy
Annecy, France
CHU-Hopital Jean Minjoz
Besançon, France
Hopital Cardio-Vasculaire Louise Pradel
Bron, France
CHU Cote De Nacre
Caen, France
CHU - Hopital Gabriel Montpied
Clermont-Ferrand, France
CHU Hopital Henri Mondor
Créteil, France
CHU - Hopital Du Bocage
Dijon, France
CHU Hopital A. Michallon
Grenoble, France
Centre Chirurgical Marie Lannelongue
Le Plessis-Robinson, France
CHRU Lille
Lille, France
Clinique De La Sauvegarde
Lyon, France
CHU Hopital La Timone
Marseille, France
Hopital Clinique Claude Bernard
Metz, France
Hopital De Mercy
Metz, France
CHU Hopital Arnaud De Villeneuve
Montpellier, France
CHU - Hopital Brabois
Nancy, France
CHU - Hopital Guillaume et Rene Laenec
Nantes, France
Hopital Prive Les Franciscaines
Nîmes, France
Groupe Hospitalier Pitié-Salpêtrière, Vascular Surgery Department
Paris, 75013, France
Groupe Hospitalier La Pitie Salpetriere
Paris, France
Hopital Bichat
Paris, France
Hopital Europeen Georges Pompidou
Paris, France
Institut Mutualiste Montsouris
Paris, France
CHU - Hopital Haut Leveque
Pessac, France
CHU - Hopital Robert Debre
Reims, France
CHU - Hopital Pontchaillou
Rennes, France
CHU Charles Nicolle
Rouen, France
Centre Cardiologique Du Nord
Saint-Denis, France
CH Felix Guyon
Saint-Denis, France
CHU De Saint Etienne
Saint-Etienne, France
Hopitaux Universitaires - Nouvel Hopital Civil
Strasbourg, France
Hôpital Rangueil, Cardiothoracic Surgery Department
Toulouse, 31009, France
Clinique Pasteur
Toulouse, France
CHU De Tours
Tours, France
Clinique Du Tonkin - Medipole
Villeurbanne, France
Related Publications (9)
Bortone AS, Schena S, D'Agostino D, Dialetto G, Paradiso V, Mannatrizio G, Fiore T, Cotrufo M, de Luca Tupputi Schinosa L. Immediate versus delayed endovascular treatment of post-traumatic aortic pseudoaneurysms and type B dissections: retrospective analysis and premises to the upcoming European trial. Circulation. 2002 Sep 24;106(12 Suppl 1):I234-40.
PMID: 12354739BACKGROUNDArko FR, Lee WA, Hill BB, Olcott C 4th, Harris EJ, Dalman RL, Fogarty TJ, Zarins CK. Impact of endovascular repair on open aortic aneurysm surgical training. J Vasc Surg. 2001 Nov;34(5):885-91. doi: 10.1067/mva.2001.118816.
PMID: 11700491BACKGROUNDKarck M, Chavan A, Hagl C, Friedrich H, Galanski M, Haverich A. The frozen elephant trunk technique: a new treatment for thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2003 Jun;125(6):1550-3. doi: 10.1016/s0022-5223(03)00045-x. No abstract available.
PMID: 12830086BACKGROUNDUsui A, Ueda Y, Watanabe T, Kawaguchi O, Ohara Y, Takagi Y, Tajima K, Nishikimi N, Ishiguchi T. Clinical results of implantation of an endovascular covered stent-graft via midsternotomy for distal aortic arch aneurysm. Cardiovasc Surg. 2000 Dec;8(7):545-9. doi: 10.1016/s0967-2109(00)00066-1.
PMID: 11068215BACKGROUNDKarck M, Kamiya H. Progress of the treatment for extended aortic aneurysms; is the frozen elephant trunk technique the next standard in the treatment of complex aortic disease including the arch? Eur J Cardiothorac Surg. 2008 Jun;33(6):1007-13. doi: 10.1016/j.ejcts.2008.02.030. Epub 2008 Apr 10.
PMID: 18406159BACKGROUNDShrestha M, Pichlmaier M, Martens A, Hagl C, Khaladj N, Haverich A. Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results. Eur J Cardiothorac Surg. 2013 Feb;43(2):406-10. doi: 10.1093/ejcts/ezs296. Epub 2012 May 31.
PMID: 22653445BACKGROUNDPatel AY, Eagle KA, Vaishnava P. Acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection. Ann Cardiothorac Surg. 2014 Jul;3(4):368-74. doi: 10.3978/j.issn.2225-319X.2014.07.06.
PMID: 25133099BACKGROUNDTsai TT, Trimarchi S, Nienaber CA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009 Feb;37(2):149-59. doi: 10.1016/j.ejvs.2008.11.032. Epub 2008 Dec 20.
PMID: 19097813BACKGROUNDJakob H, Tsagakis K. International E-vita open registry. Ann Cardiothorac Surg. 2013 May;2(3):296-9. doi: 10.3978/j.issn.2225-319X.2013.03.10.
PMID: 23977597BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Thierry Caus
Centre Hospitalier Universitaire. Heart, Chest and Vascular Centre, AMIENS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2015
First Posted
November 8, 2018
Study Start
April 1, 2016
Primary Completion
May 1, 2019
Study Completion
November 1, 2024
Last Updated
February 19, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share